ICU Medical plans sale of 2,250 common shares

ICU Medical, Inc. is the subject of a Form 144 notice covering a proposed sale of 2,250 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York.

Rhea-AI Filing Summary

ICU Medical, Inc. is the subject of a Form 144 notice covering a proposed sale of 2,250 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York. The shares have an aggregate market value of $401,209.20 and are listed on NASDAQ. The filing also lists that these shares were acquired through equity compensation events, including restricted stock vesting and performance stock units in 2025 and 2026.

Key Figures

Shares to be sold: 2,250 shares Aggregate market value: $401,209.20 Restricted stock vesting 2025: 485 shares +3 more

6 metrics

Shares to be sold 2,250 shares Common stock covered by Form 144 notice

Aggregate market value $401,209.20 Market value of 2,250 common shares

Restricted stock vesting 2025 485 shares Restricted stock vesting on 03/15/2025

Restricted stock vesting 2026 627 shares Restricted stock vesting on 03/07/2026

Performance stock units 2026 1,138 shares Performance stock units on 03/08/2026

Planned sale date 08/12/2026 Date associated with the Form 144 sale notice

Key Terms

Form 144, Restricted Stock Vesting, Performance Stock Units, Registered Plan, +1 more

5 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Restricted Stock Vesting Under a Registered Plan | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Performance Stock Units financial

"03/08/2026 | Performance Stock Units | Issuer"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

Registered Plan regulatory

"Restricted Stock Vesting Under a Registered Plan | Issuer"

A registered plan is a savings or investment account that a government recognizes for special tax treatment and rules, such as limits on how much you can put in and conditions for withdrawals. For investors it matters because those rules change how much of your gains are taxed, how quickly your money can be accessed and what strategies make sense — like a labeled jar that gives tax breaks but comes with rules about when and how you can take the money out.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ICU Medical (ICUI) report in this Form 144 filing?

The filing reports a proposed sale of 2,250 shares of common stock of ICU Medical, Inc., with an indicated aggregate market value of $401,209.20, to be executed through Morgan Stanley Smith Barney LLC.

How many ICU Medical (ICUI) shares are covered and what is their value?

The Form 144 covers 2,250 common shares of ICU Medical, Inc. with a reported aggregate market value of $401,209.20, as indicated in the securities information section.

Which broker is handling the planned ICUI share sale under Form 144?

The planned sale of 2,250 ICUI common shares is listed as being handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

On which exchange are the ICUI shares in this Form 144 listed?

The 2,250 ICU Medical common shares referenced in the Form 144 are identified as being listed on NASDAQ, as stated in the securities information section.

How were the ICU Medical (ICUI) shares in this Form 144 acquired?

The shares are reported as acquired through equity awards, including restricted stock vesting and performance stock units in March 2025 and March 2026 under registered issuer plans.

What prior equity vesting events are noted for ICU Medical (ICUI)?

The filing notes restricted stock vesting of 485 shares on 03/15/2025 and 627 shares on 03/07/2026, plus 1,138 shares from performance stock units on 03/08/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 04:25 PM Accepted by SEC EDGAR 08/12/2026 - 04:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002013412
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ICU MEDICAL, INC.
SEC File Number	001-34634
Address of Issuer	951 Calle Amanecer San Clemente CALIFORNIA 92673
Phone	(949) 366-2183
Name of Person for Whose Account the Securities are To Be Sold	BENJAMIN SOUSA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2250	401209.20	25007038	08/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2025	Restricted Stock Vesting Under a Registered Plan	Issuer			485	03/15/2025	Not Applicable
Common	03/07/2026	Restricted Stock Vesting Under a Registered Plan	Issuer			627	03/07/2026	Not Applicable
Common	03/08/2026	Performance Stock Units	Issuer			1138	03/08/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Benjamin Jerrold Sousa
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)